PHARMACEUTICAL COMPOSITIONS AND ADMINISTRATIONS THEREOF
申请人:Vertex Pharmaceuticals Incorporated
公开号:US20130131107A1
公开(公告)日:2013-05-23
The present invention relates to pharmaceutical compositions comprising a compound of Formulas I and II, optionally in combination with a Compound of Formula III and/or a Compound of Formula IV. The invention also relates to solid forms and to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis.
Alkylation of ethyl 2-(4-oxo-1,4-dihydroquinolin-2-yl)acetate by Michael addition with various alkenes has been carried out. The C-alpha alkylated intermediates so formed can be cyclized with hot polyphosphoric acid to acridine-1,9-diones.
Ghosh, Journal of the Indian Chemical Society, 1936, vol. 13, p. 326